Catalogue Search | MBRL
Search Results Heading
Explore the vast range of titles available.
MBRLSearchResults
-
DisciplineDiscipline
-
Is Peer ReviewedIs Peer Reviewed
-
Series TitleSeries Title
-
Reading LevelReading Level
-
YearFrom:-To:
-
More FiltersMore FiltersContent TypeItem TypeIs Full-Text AvailableSubjectCountry Of PublicationPublisherSourceTarget AudienceDonorLanguagePlace of PublicationContributorsLocation
Done
Filters
Reset
500,309
result(s) for
"ANIMAL RESEARCH"
Sort by:
Is anyone listening? : what animals are saying to each other and to us
by
Herzing, Denise L., author
in
Human-animal communication.
,
Animal communication.
,
Animal communication Research.
2024
\"If you could ask a dolphin one question, what would it be? What might a dolphin ask you? In her studies of marine mammal communication, researcher and author Denise Herzing has asked these and related questions for nearly forty years. In this wide-ranging and accessible book, Herzing connects research on dolphin communication to findings from Jane Goodall on chimpanzees, Dian Fossey on mountain gorillas, Cynthia Moss on African elephants, and others driving today's exploration of animal language. Considering dolphins and other nonhuman animals as colleagues instead of research subjects, she asks us to meet animals as both speakers and listeners, learning from what others have to tell us, regardless of our agendas. Our ancestors evolved with plants, animals, and the earth itself. We breathe the same oxygen, walk in the same woods, and feel the same wind and water as other life. Understanding animal communication, Herzing reminds us, helps us start to appreciate that we are mutually curious species, carefully considering each other\"-- Provided by publisher.
Is it possible to overcome issues of external validity in preclinical animal research? Why most animal models are bound to fail
2018
Background
The pharmaceutical industry is in the midst of a productivity crisis and rates of translation from bench to bedside are dismal. Patients are being let down by the current system of drug discovery; of the several 1000 diseases that affect humans, only a minority have any approved treatments and many of these cause adverse reactions in humans. A predominant reason for the poor rate of translation from bench to bedside is generally held to be the failure of preclinical animal models to predict clinical efficacy and safety. Attempts to explain this failure have focused on problems of internal validity in preclinical animal studies (e.g. poor study design, lack of measures to control bias). However there has been less discussion of another key factor that influences translation, namely the
external
validity of preclinical animal models.
Review of problems of external validity
External validity is the extent to which research findings derived in one setting, population or species can be reliably applied to other settings, populations and species. This paper argues that the reliable translation of findings from animals to humans will only occur if preclinical animal studies are both internally
and
externally valid. We review several key aspects that impact external validity in preclinical animal research, including unrepresentative animal samples, the inability of animal models to mimic the complexity of human conditions, the poor applicability of animal models to clinical settings and animal–human species differences. We suggest that while some problems of external validity can be overcome by improving animal models, the problem of species differences can never be overcome and will always undermine external validity and the reliable translation of preclinical findings to humans.
Conclusion
We conclude that preclinical animal models can never be fully valid due to the uncertainties introduced by species differences. We suggest that even if the next several decades were spent improving the internal and external validity of animal models, the clinical relevance of those models would, in the end, only improve
to some extent
. This is because species differences would continue to make extrapolation from animals to humans unreliable. We suggest that to improve clinical translation and ultimately benefit patients, research should focus instead on human-relevant research methods and technologies.
Journal Article
The Flaws and Human Harms of Animal Experimentation
2015
Nonhuman animal (“animal”) experimentation is typically defended by arguments that it is reliable, that animals provide sufficiently good models of human biology and diseases to yield relevant information, and that, consequently, its use provides major human health benefits. I demonstrate that a growing body of scientific literature critically assessing the validity of animal experimentation generally (and animal modeling specifically) raises important concerns about its reliability and predictive value for human outcomes and for understanding human physiology. The unreliability of animal experimentation across a wide range of areas undermines scientific arguments in favor of the practice. Additionally, I show how animal experimentation often significantly harms humans through misleading safety studies, potential abandonment of effective therapeutics, and direction of resources away from more effective testing methods. The resulting evidence suggests that the collective harms and costs to humans from animal experimentation outweigh potential benefits and that resources would be better invested in developing human-based testing methods.
Journal Article
The 12 Rs Framework as a Comprehensive, Unifying Construct for Principles Guiding Animal Research Ethics
by
Brink, Christiaan B.
,
Lewis, David I.
in
12Rs framework
,
Animal behavior
,
Animal experimentation
2023
Animal research ethics and animal welfare in science have become progressively tightly regulated, and ethical integrity and scientific quality, as well as social responsiveness and responsibility have become key requirements for research to be approved, funded, published, and accepted. The multitude of factors to contemplate has in some instances not only become complex, requiring a team approach, but often perceived as confusing and overwhelming. To facilitate a process of simplistic yet comprehensive conceptualization, we developed the 12 Rs Framework to act as a mind map to guide scientists, oversight structures, and other stakeholders through the myriad of ethical considerations. It unfolds into three domains of twelve encompassing ethical principles, values, and other considerations, including the animal welfare, social values, and scientific integrity domains, whilst also recognizing the diversity of local context, legal requirements, values, and cultures around the globe. In the end, it can be seen as a unifying ethical framework to foster and promote animal research ethics.
Journal Article
The secret of the bird's smart brain ... and more!
by
Rodriguez, Ana Maria, 1958- author
,
Rodriguez, Ana Maria, 1958- Animal secrets revealed
in
Birds Juvenile literature.
,
Mammals Behavior Juvenile literature.
,
Animal behavior Research Juvenile literature.
2017
\"Students will enter the world of scientists as they uncover the secrets behind birds' brains, the most underappreciated of birds senses, the way frigate birds fly non-stop, how mama bears protect their cubs, and what grunts and bellows mean for pigs and alligators\"--Amazon.com.
Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0
by
Pearl, Esther J.
,
Rooney, Kieron
,
Holgate, Stephen T.
in
Anesthesiology
,
Animal models in research
,
Animal research
2020
Improving the reproducibility of biomedical research is a major challenge. Transparent and accurate reporting is vital to this process; it allows readers to assess the reliability of the findings and repeat or build upon the work of other researchers. The ARRIVE guidelines (Animal Research: Reporting In Vivo Experiments) were developed in 2010 to help authors and journals identify the minimum information necessary to report in publications describing in vivo experiments. Despite widespread endorsement by the scientific community, the impact of ARRIVE on the transparency of reporting in animal research publications has been limited. We have revised the ARRIVE guidelines to update them and facilitate their use in practice. The revised guidelines are published alongside this paper. This explanation and elaboration document was developed as part of the revision. It provides further information about each of the 21 items in ARRIVE 2.0, including the rationale and supporting evidence for their inclusion in the guidelines, elaboration of details to report, and examples of good reporting from the published literature. This document also covers advice and best practice in the design and conduct of animal studies to support researchers in improving standards from the start of the experimental design process through to publication.
Journal Article
Why Do I Choose an Animal Model or an Alternative Method in Basic and Preclinical Biomedical Research? A Spectrum of Ethically Relevant Reasons and Their Evaluation
by
Kahrass, Hannes
,
Pietschmann, Ines
,
Mertz, Marcel
in
Animal experimentation
,
animal model
,
animal models
2024
Background: Research model selection decisions in basic and preclinical biomedical research have not yet been the subject of an ethical investigation. Therefore, this paper aims, (1) to identify a spectrum of reasons for choosing between animal and alternative research models (e.g., based on in vitro or in silico models) and (2) provides an ethical analysis of the selected reasons. Methods: In total, 13 researchers were interviewed; the interviews were analyzed qualitatively. The ethical analysis was based on the principlism approach and a value judgement model. Results: This paper presents 66 reasons underlying the choice of researchers using animal (27 reasons) or alternative models (39). Most of the reasons were assigned to the work environment (29) and scientific standards (22). Other reasons were assigned to personal attitudes (11) and animal welfare (4). Qualitative relevant normative differences are presented in the ethical analysis. Even if few reasons can be rejected outright from an ethical point of view, there are good reasons to give some more weight than others. Conclusions: The spectrum of reasons and their ethical assessment provide a framework for reflection for researchers who may have to choose between animal models and (investing in) alternatives. This can help to reflect on and ethically justify decisions.
Journal Article